Dementia Alzheimer’s type – Life with Disease

Go back

Dementia of the Alzheimer’s type is a progressive brain condition that gradually changes how a person thinks, remembers, and lives their daily life. Understanding what lies ahead can help both patients and families prepare for the journey and make the most of the time they have together.

Prognosis: What to Expect

Receiving a diagnosis of Alzheimer’s disease can feel overwhelming, and it’s natural to wonder what the future holds. This condition affects each person differently, but understanding the general outlook can help you and your loved ones prepare emotionally and practically for the road ahead.

Alzheimer’s disease is the most common cause of dementia, accounting for 60 to 80 percent of all dementia cases.[4] Currently, about 6.7 million older adults in the United States live with this condition, and that number is expected to nearly double by 2060, reaching approximately 14 million people.[5] Worldwide, an estimated 60 to 70 percent of the 55 million people with dementia have Alzheimer’s disease.[9]

The disease gets worse over time, meaning symptoms become more severe as months and years pass. In its early stages, people may experience mild memory problems, such as forgetting recent conversations or misplacing items. Over time, these difficulties progress to affect reasoning, language, behavior, and eventually the ability to perform basic daily tasks like eating, bathing, or dressing.[6]

In advanced stages, Alzheimer’s leads to serious complications. Loss of brain function can cause difficulties with swallowing, which may lead to poor nutrition or dehydration. People may also become more vulnerable to infections, such as pneumonia. These complications can ultimately result in death.[6] Alzheimer’s disease is currently the sixth leading cause of death in the United States and the fifth leading cause among Americans aged 65 and older.[7]

While these statistics may sound frightening, it’s important to remember that everyone’s experience with Alzheimer’s is unique. Some people may live for many years with mild symptoms, while others may progress more quickly. The disease typically affects people over the age of 65, though a smaller percentage of individuals develop symptoms in their 40s or 50s, known as early-onset Alzheimer’s.[8] The rate of decline and the time a person lives with the disease can vary widely depending on their age at diagnosis, overall health, and other factors.

⚠️ Important
Although there is currently no cure for Alzheimer’s disease, medications and supportive therapies are available that may help manage symptoms and potentially slow the progression of the disease in its early stages. Starting treatment early and maintaining a healthy lifestyle can make a meaningful difference in quality of life.

Natural Progression Without Treatment

If Alzheimer’s disease goes untreated, the brain continues to deteriorate in a pattern that generally follows recognizable stages. The disease is caused by abnormal deposits of proteins in the brain. These include amyloid plaques, which are clumps of a protein called beta-amyloid, and neurofibrillary tangles, which are twisted strands of another protein called tau. These abnormal protein deposits cause brain cells to die over time, and the brain physically shrinks.[6]

Without intervention, the disease moves through stages that healthcare providers often describe as mild, moderate, and severe. In the mild or early stage, a person may still function independently but will notice increasing trouble with memory, especially remembering recent events or conversations. They might repeat questions, wander and get lost even in familiar places, or have difficulty managing money and paying bills.[3]

As the disease progresses to the moderate stage, memory loss becomes more pronounced and other brain functions decline. People may have trouble recognizing friends and family members, struggle to learn new things, or behave impulsively in ways that seem out of character. They may need help with daily activities like getting dressed or preparing meals. Language difficulties become more apparent, and they may mix up words or struggle to express themselves.[3]

In the severe or late stage, individuals lose the ability to communicate verbally and require full-time assistance with all personal care. They may have trouble swallowing, become bedridden, and lose awareness of their surroundings. At this point, the brain has been so extensively damaged that basic bodily functions become compromised.[3] The time it takes to move through these stages varies greatly from person to person, but the overall trajectory is one of steady decline.

The natural progression also affects different parts of the brain in ways that change personality and behavior. As neurons stop working properly and lose their connections with other brain cells, people may experience mood swings, increased suspicion or paranoia, hallucinations, or agitation. These changes can be especially distressing for family members who feel they are losing the person they once knew.[15]

Possible Complications

Alzheimer’s disease brings with it a range of complications that go beyond memory loss. As the disease damages the brain, it affects multiple systems in the body and opens the door to additional health problems that can further reduce quality of life.

One of the most significant complications is difficulty swallowing, which usually occurs in the later stages of the disease. When swallowing becomes impaired, food or liquid can accidentally enter the lungs instead of the stomach, leading to aspiration pneumonia, a serious lung infection. This is one of the most common causes of death in people with advanced Alzheimer’s.[6]

Poor nutrition and dehydration are also frequent complications. As cognitive function declines, people may forget to eat or drink, have difficulty using utensils, or no longer recognize food. Weight loss is common, and malnutrition weakens the body’s ability to fight off infections and heal from injuries.[6]

Infections become more likely as the disease progresses. Urinary tract infections are particularly common, especially in people who develop problems with bladder control. Skin infections can occur if a person becomes bedridden and develops pressure sores from staying in one position too long. The immune system may also become less effective at fighting off illnesses.

Behavioral and psychological symptoms present another category of complications. These can include severe agitation, aggression, wandering, sleep disturbances, hallucinations, and delusions. Such symptoms are not only distressing for the person experiencing them but also place significant stress on caregivers. Sometimes these behaviors are triggered by pain, discomfort, or confusion about the environment, but they can also arise from the disease itself.[27]

Falls and injuries become more frequent as Alzheimer’s affects balance, coordination, and spatial awareness. A person may bump into furniture, have trouble with stairs, or forget how to perform movements like sitting down safely. Falls can lead to fractures, particularly hip fractures, which are serious and difficult to recover from in older adults.[15]

Depression and anxiety are also common complications. The person with Alzheimer’s may be aware, especially in the early stages, that their abilities are declining. This awareness can lead to feelings of sadness, fear, and frustration. Even as cognitive decline progresses and awareness fades, changes in brain chemistry can still cause depression and mood disturbances.

Impact on Daily Life

Alzheimer’s disease touches every aspect of a person’s daily existence. The changes it brings are not just medical; they reshape how someone experiences the world, interacts with others, and maintains their sense of self.

In the physical realm, simple tasks that were once automatic become challenging or impossible. Getting dressed may take much longer as the person struggles to remember the order in which clothes should be put on or how to fasten buttons. Bathing can become a source of confusion and anxiety. Preparing a meal involves multiple steps that may overwhelm someone whose thinking has slowed, and they might forget to turn off the stove or leave food burning.[20] As the disease progresses, even eating independently becomes difficult, and assistance is needed with the most basic acts of self-care.

Emotionally, Alzheimer’s can be devastating. People in the early stages often describe feelings of fear, sadness, and frustration as they realize their memory and thinking are slipping away. They may grieve for the life they once had and worry about becoming a burden to their family. As the disease advances and awareness diminishes, the emotional experience shifts. The person may become more easily upset, cry without clear reason, or react with anger to situations that once would not have bothered them. These emotional changes are not a reflection of who the person truly is, but rather the result of damage to the brain’s emotional regulation centers.[26]

Social life often contracts dramatically. The person may withdraw from hobbies, friendships, and community activities because they feel embarrassed about their memory problems or find it too difficult to keep up with conversations. They may stop attending social gatherings or forget the names and faces of people they have known for years. This social isolation can lead to loneliness for both the person with Alzheimer’s and their family members, who may also pull back from their own social circles to provide care.[25]

Work life is usually one of the first areas affected. People with early Alzheimer’s may have trouble organizing their workday, making decisions, or remembering appointments. Driving becomes unsafe as judgment, reaction time, and spatial awareness decline, which can be a significant loss of independence.[22] Managing finances becomes increasingly difficult, and bills may go unpaid or important documents may be lost.

Despite these challenges, there are strategies that can help maintain quality of life for as long as possible. Establishing routines and using memory aids like calendars, lists, and reminder notes can support independence in the early stages. Simplifying the home environment by reducing clutter and labeling drawers and cabinets can make daily tasks easier. Engaging in activities that bring pleasure, such as listening to favorite music, looking at photo albums, or spending time in nature, can provide comfort and connection even as cognitive abilities fade.[21]

Physical activity and social engagement remain important throughout the course of the disease. Regular walks, gentle exercises, or participation in support groups designed for people with dementia can help maintain physical health, improve mood, and provide a sense of community. Many people with Alzheimer’s benefit from structured activities that match their current abilities and interests, allowing them to experience success and enjoyment.[22]

⚠️ Important
Each person with Alzheimer’s will experience the disease differently. Some may maintain certain abilities longer than others, and personality traits often persist even as memory fades. Focusing on what the person can still do, rather than what has been lost, helps preserve dignity and self-esteem. Small adjustments to the environment and daily routines can make a big difference in maintaining independence and comfort.

Support for Family: Understanding Clinical Trials

For families facing an Alzheimer’s diagnosis, understanding the options for treatment and research can feel overwhelming. Clinical trials represent an important avenue for advancing our understanding of the disease and potentially accessing new treatments before they become widely available.

Clinical trials are research studies that test whether new drugs, therapies, or strategies are safe and effective for people with Alzheimer’s disease. These studies are carefully designed and monitored to protect participants while gathering important scientific information. Without volunteers willing to participate in clinical trials, progress toward better treatments and eventually a cure would not be possible.[20]

There are many reasons why someone with Alzheimer’s and their family might consider participating in a clinical trial. Participants may gain access to new treatments that are not yet available to the general public. They receive close monitoring and care from a specialized medical team throughout the study. Many people also find meaning and hope in contributing to research that may help future generations, even if they themselves do not benefit directly from the experimental treatment.[20]

However, it’s important to understand that clinical trials also come with uncertainties and potential risks. The experimental treatment being tested may not work, or it may cause side effects. Some trials involve a placebo, meaning some participants receive an inactive substance instead of the actual treatment, though they won’t know which they are receiving. This is necessary to determine whether the treatment is truly effective. Participation in a trial may require frequent visits to the research site, additional tests, and detailed record-keeping, which can be demanding for both the patient and their caregiver.

For families interested in exploring clinical trials, the first step is to have an open conversation with the person’s doctor. The doctor can help determine whether a clinical trial is appropriate based on the stage of the disease, overall health, and other factors. There are also online resources specifically designed to help families find clinical trials that match the patient’s situation.[20]

When considering a trial, families should ask detailed questions about what participation involves. Important questions include: What is the purpose of the study? What treatment or procedure is being tested? What are the possible risks and benefits? How long will the trial last? Will there be costs involved, or will expenses be covered? What happens if the treatment causes harm? What follow-up care is provided after the trial ends? Understanding these details helps families make an informed decision that feels right for their situation.

Family members can support their loved one in preparing for trial participation in several practical ways. Keeping organized records of medical history, current medications, and symptoms helps the research team assess eligibility. Arranging transportation to and from study visits is essential, as many trials require regular appointments. Taking notes during study visits and keeping track of any changes in symptoms or side effects helps both the research team and the family monitor progress. Providing emotional support and reassurance is equally important, as participating in research can feel uncertain or stressful.

It’s also vital that families understand they can withdraw from a clinical trial at any time, for any reason, without penalty. Participation is always voluntary, and the patient’s well-being should remain the top priority. If at any point the trial feels too burdensome or if the patient’s condition changes, stopping participation is a completely acceptable decision.

Beyond clinical trials, families should know that research participation can take other forms. Some studies focus on caregivers, examining how best to support families caring for someone with dementia. Others may involve donating brain tissue after death to help scientists better understand the disease. These contributions are invaluable to the broader effort to find better treatments and ultimately a cure for Alzheimer’s disease.

💊 Registered drugs used for this disease

List of officially registered medicines that are used in the treatment of this condition, based only on the provided sources:

  • Donepezil (Aricept) – A cholinesterase inhibitor that increases acetylcholine levels in the brain to help with memory and thinking in mild to moderate Alzheimer’s disease.
  • Galantamine (Razydyne) – A cholinesterase inhibitor prescribed for mild to moderate Alzheimer’s symptoms to help improve cognitive function.
  • Rivastigmine (Exelon) – A cholinesterase inhibitor available as a pill or patch for treating mild to moderate Alzheimer’s disease, and can be continued in later stages.
  • Memantine (Namenda) – Works by blocking excessive glutamate in the brain, used for moderate to severe Alzheimer’s disease to help slow functional decline.
  • Lecanemab (Leqembi) – An immunotherapy drug that targets and removes beta-amyloid plaques from the brain, approved for early-stage Alzheimer’s disease.
  • Donanemab (Kisunla) – An immunotherapy that targets amyloid plaques in the brain, approved for treatment of early Alzheimer’s disease.

Ongoing Clinical Trials on Dementia Alzheimer’s type

  • A study testing xanomeline tartrate and trospium chloride for treating agitation in patients with Alzheimer’s disease

    Recruiting

    1 1
    Investigated diseases:
    Czechia France Hungary Italy Poland
  • Study of KarXT (trospium chloride and xanomeline tartrate) and KarX-EC (xanomeline tartrate) for cognitive impairment in mild to moderate Alzheimer’s disease

    Recruiting

    1 1
    Investigated diseases:
    Finland France Germany Greece Italy The Netherlands +4
  • Study of xanomeline tartrate and trospium chloride combination for treating agitation in Alzheimer’s disease patients

    Recruiting

    1 1
    Investigated diseases:
    Bulgaria Croatia Greece Portugal Romania Spain
  • Study of xanomeline tartrate and trospium chloride combination for cognitive impairment in people with mild to moderate Alzheimer’s disease

    Recruiting

    1 1
    Investigated diseases:
    Croatia Czechia Germany Greece Italy Poland +2
  • Study on the Use of 18F-PI-2620 to Detect Alzheimer’s in People with Down Syndrome

    Recruiting

    1 1
    Investigated diseases:
    Investigated drugs:
    Spain
  • Study on the Accuracy of Tau PET ([18F]RO6958948) and Vizamyl (Flutemetamol 18F) in Diagnosing Mild Cognitive Symptoms and Risk of Alzheimer’s Disease

    Recruiting

    1 1 1
    Sweden
  • Study on Flutemetamol (18F) for Detecting Amyloid Pathology in Cognitively Normal Elderly at Risk for Alzheimer’s Disease

    Recruiting

    1 1 1
    Investigated diseases:
    Investigated drugs:
    The Netherlands
  • Study of Flortaucipir (18F) PET Imaging in Healthy Elderly Twins to Investigate Early Signs of Alzheimer’s Disease

    Recruiting

    1 1
    Investigated diseases:
    Investigated drugs:
    The Netherlands
  • Study on How Florquinitau (18F) Affects Brain Circuits in Early Alzheimer’s Disease Stages

    Recruiting

    1 1 1
    Investigated diseases:
    Investigated drugs:
    Belgium
  • Study on ITI-1284 for Treating Psychosis in Alzheimer’s Patients

    Recruiting

    Investigated diseases:
    Investigated drugs:
    Bulgaria Croatia Czechia Italy Poland Romania +2

References

https://www.alz.org/alzheimers-dementia/what-is-dementia/types-of-dementia

https://www.alzheimers.org.uk/about-dementia/types-dementia

https://www.nia.nih.gov/health/alzheimers-and-dementia/understanding-different-types-dementia

https://www.alz.org/alzheimers-dementia/difference-between-dementia-and-alzheimer-s

https://www.cdc.gov/alzheimers-dementia/about/index.html

https://www.mayoclinic.org/diseases-conditions/alzheimers-disease/symptoms-causes/syc-20350447

https://my.clevelandclinic.org/health/diseases/9170-dementia

https://www.webmd.com/alzheimers/alzheimers-types

https://www.who.int/news-room/fact-sheets/detail/dementia

https://www.alz.org/alzheimers-dementia/treatments

https://www.nia.nih.gov/health/alzheimers-treatment/how-alzheimers-disease-treated

https://www.mayoclinic.org/diseases-conditions/alzheimers-disease/diagnosis-treatment/drc-20350453

https://www.nhs.uk/conditions/alzheimers-disease/treatment/

https://www.alz.org/alzheimers-dementia/treatments/medications-for-memory

https://my.clevelandclinic.org/health/diseases/9164-alzheimers-disease

https://www.alzheimers.org.uk/about-dementia/treatments

https://www.brain.northwestern.edu/dementia/ad/treatment.html

https://www.brightfocus.org/resource/treatments-alzheimers-disease/

https://dementech.com/2022/06/28/top-6-best-treatments-for-early-dementia/

https://www.alzheimers.gov/life-with-dementia/tips-caregivers

https://www.alzheimers.gov/life-with-dementia/tips-dementia

https://www.alz.org/help-support/i-have-alz/live-well/tips-for-daily-life

https://www.nia.nih.gov/health/alzheimers-and-dementia/tips-living-alone-early-stage-dementia

https://www.alzheimers.org.uk/get-support/help-dementia-care/understanding-supporting-person-dementia

https://www.alz.org/help-support/i-have-alz/live-well/taking-care-of-yourself

https://www.helpguide.org/aging/dementia/living-with-alzheimers-or-dementia

https://www.nhs.uk/conditions/dementia/living-with-dementia/behaviour/

https://medlineplus.gov/diagnostictests.html

https://www.questdiagnostics.com/

https://www.healthdirect.gov.au/diagnostic-tests

https://www.who.int/health-topics/diagnostics

https://www.yalemedicine.org/clinical-keywords/diagnostic-testsprocedures

https://www.nibib.nih.gov/science-education/science-topics/rapid-diagnostics

FAQ

Is Alzheimer’s disease the same as dementia?

No, they are not the same. Dementia is an umbrella term that describes a group of symptoms affecting memory, thinking, and daily functioning. Alzheimer’s disease is the most common cause of dementia, accounting for 60 to 80 percent of cases, but there are other types of dementia such as vascular dementia, Lewy body dementia, and frontotemporal dementia.

Can Alzheimer’s disease be cured?

Currently, there is no cure for Alzheimer’s disease. However, medications are available that may temporarily improve symptoms or slow the progression of the disease in its early stages. Research continues to search for treatments that could stop or reverse the disease process.

At what age do people typically develop Alzheimer’s disease?

Most people with Alzheimer’s are diagnosed after age 65, with the risk increasing significantly with age. About 5 to 8 percent of people over 65 have dementia, and this number doubles every five years. However, up to 5 percent of people develop early-onset Alzheimer’s in their 40s or 50s.

What causes Alzheimer’s disease?

Alzheimer’s disease is caused by abnormal deposits of proteins in the brain, specifically amyloid plaques and tau tangles. These deposits cause brain cells to die over time and the brain to shrink. Many factors contribute to the disease, including genetics, age, lifestyle, and possibly other health conditions, but the exact cause is still being researched.

How long can someone live with Alzheimer’s disease?

The progression of Alzheimer’s varies greatly from person to person. Some people may live many years with the disease, while others may progress more quickly. The time from diagnosis to death can range from a few years to over a decade, depending on the person’s age at diagnosis, overall health, and other factors. Advanced stages can lead to complications such as infections or difficulty swallowing that may cause death.

🎯 Key takeaways

  • Alzheimer’s disease is the most common form of dementia and currently affects about 6.7 million Americans, with that number expected to double by 2060.
  • The disease progresses through stages from mild memory problems to severe decline requiring full-time care, but the timeline varies greatly among individuals.
  • While there is no cure, several medications can help manage symptoms or slow progression in early stages, including newer immunotherapy drugs that target amyloid plaques.
  • Complications such as aspiration pneumonia, malnutrition, infections, and falls become more common as the disease progresses and can be life-threatening.
  • The impact extends beyond memory to affect every area of daily life, including physical abilities, emotional well-being, social connections, and independence.
  • Clinical trials offer potential access to new treatments and contribute valuable information to research, though they involve uncertainties and require careful consideration.
  • Families play a crucial role in supporting loved ones with Alzheimer’s, from helping with daily tasks to making decisions about care and treatment options.
  • Maintaining routines, staying physically and socially active, and creating a safe environment can help preserve quality of life throughout the disease course.

Connected medications: